Page last updated: 2024-09-03

nitroaspirin and Diabetes Mellitus, Type 2

nitroaspirin has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beghi, C; Bonadonna, S; Corradi, D; De Cicco, G; Gherli, T; Giustina, A; Lorusso, R; Maestri, R; Mancini, T; Poli, E	1

Trials

1 trial(s) available for nitroaspirin and Diabetes Mellitus, Type 2

Article	Year
Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG. International journal of cardiology, 2007, May-31, Volume: 118, Issue:2 Topics: Acetylcholine; Aged; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fibrinolytic Agents; Humans; Male; Nitroprusside; Saphenous Vein; Transplants; Vasoconstriction; Vasodilator Agents	2007

Article

Year

Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG.

International journal of cardiology, 2007, May-31, Volume: 118, Issue:2

Topics: Acetylcholine; Aged; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fibrinolytic Agents; Humans; Male; Nitroprusside; Saphenous Vein; Transplants; Vasoconstriction; Vasodilator Agents

2007